Market Overview

UPDATE: Oppenheimer Reiterates a Perform on Apollo Group

Share:
Related APOL
Stocks Hitting 52-Week Lows
Mid-Day Market Update: Juno Therapeutics Jumps Following Announcement of 10-Year Collaboration With Celgene

Oppenheimer maintains a Perform rating on Apollo Group (NASDAQ: APOL).

Oppenheimer comments, “Positively, APOL raised its full-year operating income guidance range and tightened the top end of revenue guidance. Despite the increased operating income guidance, the starts environment is expected to remain choppy as APOL warned of likely 4Q12 negative starts growth. Although APOL has made strides in managing the potential outcomes of its students, new enrollment volatility remains a challenge. We remain on the sidelines pending enhanced clarity into enrollment (particularly starts).”

Apollo Group closed at $32.47 on Monday.

Latest Ratings for APOL

DateFirmActionFromTo
Jun 2015Bank of AmericaDowngradesNeutralUnderperform
Jun 2015BMO CapitalMaintainsOutperform
Jun 2015Deutsche BankMaintainsHold

View More Analyst Ratings for APOL
View the Latest Analyst Ratings

Posted-In: OppenheimerAnalyst Color Reiteration Analyst Ratings

 

Related Articles (APOL)

Get Benzinga's Newsletters